However, it was found that tangeretin markedly inhibited the increase in IL‐1β and IL‐6 levels with CIS at a dose of 10 mg/kg (p < 0.05 and p < 0.01, respectively). The gene discussed is IL1B; the disease is in situ carcinoma.